Colestipol Hydrochloride Patent Expiration

Colestipol Hydrochloride was first introduced by Pfizer Inc in its drug Flavored Colestid on Approved Prior to Jan 1, 1982. Another drug containing Colestipol Hydrochloride is Colestid. 6 different companies have introduced drugs containing Colestipol Hydrochloride.


Colestipol Hydrochloride Patents

Given below is the list of patents protecting Colestipol Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Colestid US5490987 Tableting of colestipol hydrochloride Feb 13, 2013

(Expired)

Pfizer



Colestipol Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Colestipol Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Colestipol Hydrochloride. The first generic version for Colestipol Hydrochloride was by Impax Laboratories Inc and was approved on May 2, 2006. And the latest generic version is by Riconpharma Llc and was approved on Dec 3, 2024.

Given below is the list of companies who have filed for Colestipol Hydrochloride generic, along with the locations of their manufacturing plants worldwide.